ANAC News
Archived Headlines
- Anacor Pharmaceuticals slashes estimated IPO price to $5, announces concurrent private placement 11/23/10
- 4 IPOs planned for the week of Nov 22 11/22/10
- 10 IPOs planned for the week of Nov 15 11/15/10
- Anacor Pharmaceuticals discloses terms for $80 million IPO 11/03/10
- Anacor Pharmaceuticals refiles for $86 million IPO 09/10/10
Anacor Pharmaceuticals quiet period ends January 2
Anacor Pharmaceuticals, which is developing treatments for nail fungus and psoriasis using boron-based chemistry, will see its quiet period end on Sunday, January 2. On November 23, the company raised $60 million by offering 12 million shares at $5, below the...read more
US IPO market slows pace in shortened holiday week with four tepid debuts
The US IPO market slowed this week with four small companies raising less than $100 million in their deals and seeing lukewarm receptions from IPO investors. Biotechs Zogenix (ZGNX) and...read more
Chinese real estate agency services provider SYSWIN prices IPO at $7 per ADS; raises $67 million
SYSWIN, a leading provider of real estate agency services to property developers in Beijing, raised $67 million by selling 9.6 million ADSs at $7, well below its originally anticipated terms of 12 million ADSs at a price of $9.25 to $11.25. Earlier on Tuesday,...read more
Anacor Pharmaceuticals prices upsized IPO at $5, below the original range of $16-$18
Anacor Pharmaceuticals, which is developing treatments for nail fungus and psoriasis using boron-based chemistry, raised $60 million by offering 12 million shares at $5, as outlined in its amendment filed with the SEC earlier today. The biotech had originally...read more